Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer OTC Drugs

Rite Aid Chairman Green Refocuses Marketing Strategy On Product Promotion

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

One of Rite Aid Chairman Leonard Green's priorities to help the struggling drug store chain rebound is to revise its market strategy to emphasize promotion of products, sales and services, the company said.

You may also be interested in...



Rite Aid Heads West To Fill Executive Positions, Taps Fred Meyer Talent

Rite Aid's appointment of four former Fred Meyer executives to its top management signals a change in the drug store chain's West Coast business strategy.

Rite Aid Heads West To Fill Executive Positions, Taps Fred Meyer Talent

Rite Aid's appointment of four former Fred Meyer executives to its top management signals a change in the drug store chain's West Coast business strategy.

Rite Aid Hopes For Greener Pastures After Cutting CEO Grass

Rite Aid will operate under a one-year turnaround deadline following the departure of CEO Martin Grass and the infusion of $300 mil. from Leonard Green & Partners.

Table

View full table

Topics

Tags:
Consumer OTC Drugs
Latest Headlines

Patent Office Issues Proposed Rule For Rarely Successful Director Review Requests

Medicare Spending Forecast For Leqembi Reflects CMS Angst About Alzheimer’s Drug Costs

US FDA Drugs Center Launches Clinical Trial Innovation Hub With Demonstration Projects

EMA Releases Guidance On How & When Its RWE Generation Service Can Be Used

See All
UsernamePublicRestriction

Register

PS090596

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By